UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046919
Receipt number R000053518
Scientific Title A cohort study of arrhythmia screening in apheresis donors by analyzing fingertip pulse wave
Date of disclosure of the study information 2022/03/01
Last modified on 2024/08/20 14:05:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Arrhythmia screening by using pulse oximeter

Acronym

Easy health check by fingertip device

Scientific Title

A cohort study of arrhythmia screening in apheresis donors by analyzing fingertip pulse wave

Scientific Title:Acronym

Arrhythmia screening trial by using pulse oximeter

Region

Japan


Condition

Condition

Arrhythmia

Classification by specialty

Medicine in general Blood transfusion Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In apheresis donors (>40 years old), we will examine the pulse wave to detect asymptomatic arrhythmia cases by fingertip pulse oximeter. We expect the safer effect for apheresis donors by this noninvasive and easy screening device.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Reduction of donation adverse cases

Key secondary outcomes

Detection of asymptomatic arrhythmia


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Additional electrocardiogram examination

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

Apheresis donors

Key exclusion criteria

Subjects who are deferred by pre-donation examination

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Sawamura

Organization

Japanese Red Cross Tokyo Metropolitan Blood Center

Division name

Department of Medicine

Zip code

162-8639

Address

12-2, Wakamatsu-cho, Shinjuku-ku, Tokyo

TEL

0352723532

Email

y-sawamura@ktks.bbc.jrc.or.jp


Public contact

Name of contact person

1st name Yoshihiro
Middle name
Last name Sawamura

Organization

Japanese Red Cross Tokyo Metropolitan Blood Center

Division name

Department of Medicine

Zip code

162-8639

Address

12-2, Wakamatsu-cho, Shinjuku-ku, Tokyo

TEL

0352723532

Homepage URL


Email

y-sawamura@ktks.bbc.jrc.or.jp


Sponsor or person

Institute

Japanese Red Cross Tokyo Metropolitan Blood Center
Department of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japanese Red Cross Society
Blood Service Headquarter

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japanese Red Cross Society Blood Service Headquater Central Blood Institute

Address

2-1-67 Tatsumi Koto-ku Tokyo

Tel

0355347508

Email

kenkyu1@jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京都赤十字血液センター(東京都)/Japanese Red Cross Tokyo Metropolitan Blood Center(Tokyo)


Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

3549

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 12 Month 17 Day

Date of IRB

2021 Year 12 Month 17 Day

Anticipated trial start date

2022 Year 03 Month 22 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Up to 2023/1/31, we studied 1,556 donors for monitoring. Our study is ongoing now.


Management information

Registered date

2022 Year 02 Month 15 Day

Last modified on

2024 Year 08 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053518